Northern New Jersey Community Clinical Oncology Program

描述（由申请人提供）：北方新泽西CCOP（NNJCCOP） 提供癌症治疗和癌症控制的临床试验， 新泽西840万人口中的近一半，以及邻近的 纽约和宾夕法尼亚。有43名医生参与了试验， 包括儿科和成人血液学/肿瘤学家、外科医生、泌尿科医生， 放射肿瘤学家、妇科肿瘤学家和泌尿科医生。增设37 医生积极参与CCOP的工作。广泛的外联 确保广泛的医生转诊以控制癌症。它们由一个 训练有素的研究护士、药剂师和数据管理员骨干。的 CCOP建立了有效和经验丰富的基础设施，以确保 符合临床研究的最高标准。医生 建立在三个临床紧密结合的悠久传统之上， 在两个医院的医院。哈肯萨克大学医学中心（HUMC） 包括一个儿科项目，明天的孩子？研究所（TCI）和 成人项目，北方新泽西癌症中心（NNJCC）。特里尼塔斯 医院，一个组成部分的医院居住在联合县，服务高 少数民族人口。这两家医院是肿瘤治疗的主要来源 在他们的集水区，总共增加了2400多个新的癌症 患者每年该计划的具体目标是：减少癌症 通过扩大临床试验提高发病率、发病率和死亡率; 开发创造性和创新性的沟通，协作和 在医生、医疗服务提供者和公民中开展教育，以加速癌症 预防、检测和治疗;确保更广泛地参与试验 少数民族和女性参与者;并确保高标准的 癌症试验的卓越和质量。强有力的领导，有效的 组织结构和良好的业绩记录支持的目标， 加速外联、广泛征聘、扩大应计制、有效后续行动， 准确的数据管理，符合质量保证标准， 积极参与新临床试验的设计和实施。 在2002-2007年赠款期间，NNJCCOP预计将有1 482名成年人受益， 学分（420治疗和1062癌症控制和随访）和318.2 儿科学分，298治疗和20.2癌症控制学分。这 代表1800.2个信用额的5年预计应计总额。

DESCRIPTION (provided by applicant): The Northern New Jersey CCOP (NNJCCOP) provides access to clinical trials for cancer treatment and cancer control to almost half of the 8.4 million population of New Jersey, as well as adjacent New York and Pennsylvania. Forty-three physicians have access to trials, including pediatric and adult hematology/oncologists, surgeons, urologists, radiation oncologists, gynecologic oncologists and urologists. 37 Additional physicians are actively involved in the work of the CCOP. Extensive outreach ensures broad physician referral for cancer control. They are supported by a well-trained cadre of research nurses, pharmacists and data managers. The CCOP has created an effective and experienced infrastructure to ensure compliance with the highest standards of clinical research. The physicians build on a long tradition of closely-knit integration at the three clinical sites at two component hospitals. Hackensack University Medical Center (HUMC) includes a pediatric program, Tomorrows Children?s Institute (TCI) and an adult program, the Northern New Jersey Cancer Center (NNJCC). Trinitas Hospital, a component hospital resides in Union County, serving a high minority population. The two hospitals are primary sources of oncology care in their catchment areas and together accrue more than 2400 new cancer patients each year. The specific aims of the program are to: reduce cancer incidence, morbidity and mortality through expansion of clinical trials; develop creative and innovative means of communication, collaboration and education among physicians, health providers and citizens to accelerate cancer prevention, detection and treatment; ensure broader participation in trials among minority and female participants; and assure high standards of excellence and quality in cancer trials. Strong leadership, an effective organizational structure and proven track record support the goals of accelerated outreach, broad recruitment, expanded accrual, effective followup, accurate data management, compliance with quality assurance standards and active participation in the design, and implementation of new clinical trials. For the grant period, 2002-2007, the NNJCCOP projects accrual of 1482 adult credits (420 treatment and 1062 cancer control and follow-up) and 318.2 pediatric credits with 298 treatments and 20.2 cancer control credits. This represents a combined 5-year projected accrual of 1800.2 credits.